APOE and neoplasm: In this context, tumor-derived apolipoprotein E (APOE) binds to TREM2 on TAMs, triggering downstream activation of the DAP12–SYK signaling cascade, which subsequently engages PI3K–AKT and MAPK pathways to initiate a neurogenic transcriptional program [76].